Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMPD1 | P17405 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 2/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL17143222 | 0.98 | LMNA (0.38) | SMPD1MEN1KMT2ACYP2C19RECQL | |
| SCHEMBL192296 | 0.84 | MEN1 (0.39) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL28733151 | 0.83 | SMN1; SMN2 (0.32) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL907147 | 0.82 | SMPD1 (0.45) | SMPD1BLMLAP3 | |
| SCHEMBL8160746 | 0.80 | SMPD1 (0.56) | SMPD1MEN1KMT2ACYP1A2LMNA | |
| SCHEMBL27735835 | 0.79 | LMNA (0.56) | MEN1KMT2ACYP2C19RECQLCYP1A2 | |
| SCHEMBL5481597 | 0.78 | SMPD1 (0.59) | SMPD1MEN1KMT2ACYP1A2LMNA | |
| SCHEMBL744377 | 0.78 | SMPD1 (0.59) | SMPD1MEN1KMT2ACYP1A2LMNA | |
| SCHEMBL1044719 | 0.78 | SMPD1 (0.59) | SMPD1MEN1KMT2ACYP1A2LMNA | |
| SCHEMBL27699114 | 0.78 | SMPD1 (0.59) | SMPD1MEN1KMT2ACYP1A2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4626483-A1 | SURFACE MODIFIED CARBON NANOTUBES AND USES THEREOF | Luna Labs USA, LLC (US) | 2025-10-08 | — | — | EP | claimed |
| WO-2024118249-A1 | SURFACE MODIFIED CARBON NANOTUBES AND USES THEREOF | LUNA LABS USA, LLC (US) | 2024-06-06 | — | — | WO | claimed |
| US-20220202952-A1 | IMMUNOSTIMULATORY LIPOPLEX, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOSTIMULATORY LIPOPLEX, AND USES THEREOF | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2022-06-30 | — | — | US | claimed |
| EP-4019006-A1 | IMMUNOSTIMULATORY LIPOPLEX, PHARMACEUTICAL COMPOSITION INCLUDING IMMUNOSTIMULATORY LIPOPLEX, AND USES THEREOF | Industrial Technology Research Institute (TW) | 2022-06-29 | — | — | EP | claimed |
| CN-114437128-A | Choline phosphate modified paclitaxel medicine and preparation method and application thereof | 中国科学院长春应用化学研究所 | 2022-05-06 | — | — | CN | claimed |
| CN-114286671-A | Compositions and methods for biological delivery vehicles | DNALite治疗学公司 | 2022-04-05 | — | — | CN | claimed |
| CN-108779074-A | Plant virus movement protein and its application method | 分子传递有限公司 | 2018-11-09 | — | — | CN | claimed |
| EP-1049491-A1 | GENE THERAPY OF TUMORS USING NON-VIRAL DELIVERY SYSTEM | Perez-Soler, Roman (US) | 2000-11-08 | — | — | EP | claimed |
| WO-1999034835-A1 | GENE THERAPY OF TUMORS USING NON-VIRAL DELIVERY SYSTEM | PEREZ SOLER ROMAN (US) | 1999-07-15 | — | — | WO | claimed |
| EP-4452238-B1 | METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES | TORINO POLITECNICO (IT) | 2026-02-04 | — | — | EP | disclosed |
| EP-4626483-A1 | SURFACE MODIFIED CARBON NANOTUBES AND USES THEREOF | Luna Labs USA, LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250057779-A1 | METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES | POLITECNICO DI TORINO (75%) (IT) | 2025-02-20 | — | — | US | disclosed |
| EP-4452238-A1 | METHOD FOR THE PREPARATION OF HYBRID POLYMERIC NANOPARTICLES FOR THE RELEASE OF OLIGONUCLEOTIDE DRUGS IN PHARMACOLOGICAL THERAPIES FOR REGENERATIVE, CURATIVE, AND PREVENTIVE PURPOSES | Politecnico Di Torino (IT) | 2024-10-30 | — | — | EP | disclosed |
| WO-2024118249-A1 | SURFACE MODIFIED CARBON NANOTUBES AND USES THEREOF | LUNA LABS USA, LLC (US) | 2024-06-06 | — | — | WO | disclosed |
| EP-0988061-A4 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-1049491-A1 | GENE THERAPY OF TUMORS USING NON-VIRAL DELIVERY SYSTEM | Perez-Soler, Roman (US) | 2000-11-08 | — | — | EP | disclosed |
| US-6143276-A | ADMINISTERING TO THE PATIENT A COMPOSITION COMPRISING A BIOACTIVE AGENT AND A GASEOUS PRECURSOR CAPABLE OF UNDERGOING PHASE TRANSITION TO A GAS AT A REGION OF ELEVATED TEMPERATURE IN THE PATIENT | IMARX PHARMACEUTICAL CORP. (US) | 2000-11-07 | — | — | US | disclosed |
| EP-0988061-A1 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-29 | — | — | EP | disclosed |
| WO-1999034835-A1 | GENE THERAPY OF TUMORS USING NON-VIRAL DELIVERY SYSTEM | PEREZ SOLER ROMAN (US) | 1999-07-15 | — | — | WO | disclosed |
| WO-1998042384-A1 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | disclosed |